Historique
Auteur S. CRAFT
Documents disponibles écrits par cet auteur (7)
Ajouter le résultat à votre sélection Affiner la recherche
T. P. FREEMAN ; S. CRAFT ; J. WILSON ; S. STYLIANOU ; M. ELSOHLY ; M. DI FORTI ; M. T. LYNSKEY | 2021
Dans Addiction (Vol.116, n°5, May 2021) Article : PériodiqueBACKGROUND AND AIMS: Cannabis products with high delta-9-tetrahydrocannabinol (THC) concentrations carry an increased risk of addiction and mental health disorders, while it has been suggested that cannabidiol (CBD) may moderate the effects of T[...]
S. CRAFT ; P. SUNDERLAND ; M. F. MILLEA ; C. R. PUDNEY ; O. B. SUTCLIFFE ; T. P. FREEMAN | 2025
Dans Addiction (Vol.120, n°3, March 2025) Article : PériodiqueBACKGROUND AND AIMS: In the United Kingdom and internationally, synthetic cannabinoids (SCs) are a common adulterant in illicitly sourced vaping products. Recently, their use is increasingly being linked to severe health effects, particularly am[...]
OEDT = EMCDDA ; T. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; P. GRIFFITHS ; D. POTTER ; S. CRAFT ; A. ENGLUND ; M. LYNSKEY ; R. SEDEFOV | 2019
RapportENGLISH: This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to in[...]
A. AUSTIN ; L. FAVRIL ; S. CRAFT ; P. THLIVERI ; T. P. FREEMAN | 2023
Dans International Journal of Drug Policy (Vol.122, December 2023) Article : PériodiqueBackground: About a third of people use drugs during their incarceration, which is associated with multiple adverse health and criminal justice outcomes. Many studies have examined factors associated with in-prison drug use, but this evidence ha[...]
S. CRAFT ; A. AUSTIN ; T. TOOTH ; C. GLOVER ; T. GARRETT ; I. S. BLAGBROUGH ; P. SUNDERLAND ; C. R. PUDNEY ; T. P. FREEMAN | 2023
Dans International Journal of Drug Policy (Vol.122, December 2023) Article : PériodiqueIntroduction: Synthetic cannabinoids (i.e. Spice) are a major public health problem in UK prisons, however, research in this area is limited. Here we aimed to draw comparisons between people with and without experience of using synthetic cannabi[...]Nouveauté
G. E. COZIER ; M. GARDNER ; S. CRAFT ; M. SKUMLIEN ; J. SPICER ; R. ANDREWS ; A. POWER ; T. HAINES ; R. BOWMAN ; A. E. MANLEY ; P. SUNDERLAND ; O. B. SUTCLIFFE ; S. M. HUSBANDS ; L. HINES ; G. TAYLOR ; T. P. FREEMAN ; J. SCOTT ; C. R. PUDNEY | 2025
Dans Addiction (Vol.120, n°10, October 2025) Article : PériodiqueBACKGROUND AND AIMS: People who use synthetic cannabinoids (SCs) report debilitating side effects and withdrawal symptoms, coupled with dependence. In the UK, SC use was believed to be largely restricted to prison, where they are the most common[...]![Turning down the spice: tackling the problems of synthetic cannabinoids [Editorial]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_86303.webp)
M. SKUMLIEN ; S. CRAFT ; J. SCOTT ; T. P. FREEMAN | 2023
Dans British Medical Journal (Vol.382, n°8398, 16 September 2023) Article : PériodiqueNational and international policies are key to reducing use and harm Synthetic cannabinoids, colloquially known as "spice," are a class of structurally diverse novel psychoactive substances that were originally designed to mimic the effects of [...]
